Decentralized Trials in Rare Disease: What’s Working & What’s Not?

Time: 1:45 pm
day: Day Two

Details:

  • Which aspects of decentralized trials (e.g. home nursing, remote monitoring, eConsent) are proving most viable in rare indications?
  • Where do challenges remain – such as diagnostics, sample collection, or maintaining data integrity?
  • How can we strike the right balance between virtual convenience and medical oversight?

Speakers: